Luxsol

**Luxsol** is an investigational, proprietary copper-containing vaginal cream developed by CDA Research Group for bacterial vaginosis. In the registered proof-of-concept study NCT02197182, the product was administered intravaginally once nightly for 10 consecutive nights and compared with metronidazole gel. Public trial records identify Luxsol only as a copper-containing cream; they do not disclose the exact copper species, concentration, full formulation, or a defined molecular target. The bacterial-vaginosis study was terminated, and Luxsol has no identified approved product label or assigned INN.

Brand names

Luxsol

Other names

Luxsol Topical Cream